Related Experiment Video
Updated: Apr 16, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
CDK2 phosphorylation regulates the protein stability of KLF10 by interfering with binding of the E3 ligase SIAH1
Ching-Hui Lin1, Shu-Yu Lin2, Hsuen-Wen Chang3
1National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan.
Abstract:
Downregulation of multiple cell cycle-regulatory molecules is a dominant event in TGF-β1-mediated growth inhibition of human carcinoma cells. It is known that KLF10 mimics the anti-proliferative and apoptotic effects that TGF-β1 has on epithelial cell growth and the growth of various tumor cells; based on these findings it is considered as a tumor suppressor. KLF10 protein expression is tightly associated with cell cycle-dependent events. However, the regulatory mechanism and its biological meaning have not been identified. In this study, we have demonstrated that KLF10 is a substrate of CDK2/cyclin E and can be phosphorylated. We also have shown that KLF10 efficiently binds to CDK2, while binding much less to CDK4, and displaying no binding to Cdk6. Using mass spectrometry, site direct mutagenesis, in vitro kinase assays and depletion assays, we have established that CDK2 phosphorylates Ser206, which subsequently affects the steady state level of KLF10 in cells. Our studies have also proved that CDK2 up-regulates the protein level of KLF10 through reducing its association with SIAH1, a KLF10 E3-ubiqutin ligase involved in proteasomal degradation. Taken all together, these findings indicate that CDK2-dependent phosphorylation regulates KLF10 stability and that this affects the role of KLF10 in cell.
Insights
Cyclin-dependent kinase 2 (CDK2) phosphorylation stabilizes the tumor suppressor KLF10 by preventing its degradation. This CDK2-dependent regulation impacts KLF10
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Transforming growth factor-beta 1 (TGF-β1) inhibits human carcinoma cell proliferation via cell cycle regulation.
- KLF10, a known tumor suppressor, mimics TGF-β1's anti-proliferative and apoptotic effects on epithelial and tumor cells.
- KLF10 protein levels are linked to cell cycle events, but its regulatory mechanisms remain unclear.
Purpose of the Study:
- To elucidate the regulatory mechanism of KLF10 protein expression.
- To identify the specific kinase responsible for KLF10 phosphorylation.
- To understand how KLF10 phosphorylation affects its stability and function in cell cycle regulation.
Main Methods:
- Mass spectrometry to identify phosphorylation sites.
- Site-directed mutagenesis to confirm kinase activity.
- In vitro kinase assays to assess CDK2 interaction and phosphorylation.
- Depletion assays to evaluate the role of SIAH1 in KLF10 degradation.
Main Results:
- KLF10 is phosphorylated by CDK2/cyclin E, with strong binding to CDK2.
- CDK2 specifically phosphorylates KLF10 at Serine 206 (Ser206).
- CDK2-mediated phosphorylation stabilizes KLF10 by reducing its interaction with the E3-ubiquitin ligase SIAH1, thereby inhibiting proteasomal degradation.
Conclusions:
- CDK2-dependent phosphorylation is a key regulator of KLF10 protein stability.
- This phosphorylation mechanism influences KLF10's role as a tumor suppressor.
- Understanding this pathway offers insights into controlling cell proliferation in human carcinomas.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Anaphase Promoting Complex
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...